Evidence map›Paper›PMID 34065967›Full record

ArticleCancers2021

High Temperature Drives Topoisomerase Mediated Chromosomal Break Repair Pathway Choice.

Mohamed E Ashour, Walaa Allam, Waheba Elsayed, Reham Atteya, Menattallah Elserafy, Sameh Magdeldin, Mohamed K Hassan, Sherif F El-Khamisy

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.3field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Mohamed E AshourCenter for Genomics, Helmy Institute for Medical Science, Zewail City of Science and Technology, Giza 12578, Egypt.
Walaa AllamCenter for Genomics, Helmy Institute for Medical Science, Zewail City of Science and Technology, Giza 12578, Egypt.
Waheba ElsayedCenter for Genomics, Helmy Institute for Medical Science, Zewail City of Science and Technology, Giza 12578, Egypt.ORCID 0000-0002-4306-3023
Reham AtteyaCenter for Genomics, Helmy Institute for Medical Science, Zewail City of Science and Technology, Giza 12578, Egypt.
Menattallah ElserafyCenter for Genomics, Helmy Institute for Medical Science, Zewail City of Science and Technology, Giza 12578, Egypt.ORCID 0000-0002-0272-8498
Sameh MagdeldinProteomics and Metabolomics Research Program, Children Cancer Hospital (CCHE 57357), Cairo 11441, Egypt.ORCID 0000-0002-7507-9935
Mohamed K HassanCenter for Genomics, Helmy Institute for Medical Science, Zewail City of Science and Technology, Giza 12578, Egypt.
Sherif F El-KhamisyThe Healthy Lifespan and the Neuroscience Institutes, University of Sheffield, South Yorkshire, Sheffield S10 2TN, UK.ORCID 0000-0003-2721-7763
Zewail City of Science and Technology · EGSuez Canal University · EGUniversity of Bradford · GB

Funding

Academy of Scientific Research and Technology ASRT-45Lister Institute of Preventive Medicine 137661Science and Technology Development Fund 22935Wellcome Trust 103844
6 · The paper itself

Abstract

Cancer-causing mutations often arise from inappropriate DNA repair, yet acute exposure to DNA damage is widely used to treat cancer. The challenge remains in how to specifically induce excessive DNA damage in cancer cells while minimizing the undesirable effects of genomic instability in noncancerous cells. One approach is the acute exposure to hyperthermia, which suppresses DNA repair and synergizes with radiotherapy and chemotherapy. An exception, however, is the protective effect of hyperthermia on topoisomerase targeting therapeutics. The molecular explanation for this conundrum remains unclear. Here, we show that hyperthermia suppresses the level of topoisomerase mediated single- and double-strand breaks induced by exposure to topoisomerase poisons. We further uncover that, hyperthermia suppresses hallmarks of genomic instability induced by topoisomerase targeting therapeutics by inhibiting nuclease activities, thereby channeling repair to error-free pathways driven by tyrosyl-DNA phosphodiesterases. These findings provide an explanation for the protective effect of hyperthermia from topoisomerase-induced DNA damage and may help to explain the inverse relationship between cancer incidence and temperature. They also pave the way for the use of controlled heat as a therapeutic adjunct to topoisomerase targeting therapeutics.

Indexed as

ageingcancergenomic instabilityhyperthermiaTDP1TDP2topoisomerase

Identifiers

PMID34065967
PMCPMC8151962
OpenAlexW3162530385

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.